Alice Ruo Wei Tang (@arwtmd) 's Twitter Profile
Alice Ruo Wei Tang

@arwtmd

building things in precision oncology, brain tumor doctor, displaced European | @ImperialMed @HarvardNeuroMDs

ID: 1164290700076376066

calendar_today21-08-2019 21:38:38

41 Tweet

200 Followers

377 Following

Neurology Journal (@greenjournal) 's Twitter Profile Photo

Neurology Podcast: Drs. Justin Abbatemarco and Alice Tang discuss the association between immune status and herpes simplex virus encephalitis. Listen now: bit.ly/4duWs2z Read the related article in Neurology: bit.ly/3WvoC7y #NeuroTwitter Alice Ruo Wei Tang Justin Abbatemarco

Alice Ruo Wei Tang (@arwtmd) 's Twitter Profile Photo

The neurologist will see you now 🧠 congratulations to the newly minted Harvard Neurology Class of 2024! Thanks to everyone who was woken up by an aberrant page, waited for us as we left the hospital late (again), and supported us through this journey Mass General Brigham/HMS Neurology Residency

The neurologist will see you now 🧠 congratulations to the newly minted Harvard Neurology Class of 2024! Thanks to everyone who was woken up by an aberrant page, waited for us as we left the hospital late (again), and supported us through this journey <a href="/harvardneuromds/">Mass General Brigham/HMS Neurology Residency</a>
U.S. FDA (@us_fda) 's Twitter Profile Photo

Today, the FDA is taking a groundbreaking step to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods. fda.gov/news-events/pr…

Today, the FDA is taking a groundbreaking step to advance public health by replacing animal testing in the development of monoclonal antibody therapies and other drugs with more effective, human-relevant methods.
fda.gov/news-events/pr…
Paolo Tarantino (@ptarantinomd) 's Twitter Profile Photo

Results from OptiTROP-B01 out in Nature Medicine. The TROP2-ADC sacituzumab tirumotecan improved PFS and OS in highly pretreated mTNBC, irrespective of Trop2 exp. Results similar to ASCENT. Approved in China, may soon also reach the west (4th topo1 ADC). nature.com/articles/s4159…

Results from OptiTROP-B01 out in <a href="/NatureMedicine/">Nature Medicine</a>. The TROP2-ADC sacituzumab tirumotecan improved PFS and OS in highly pretreated mTNBC, irrespective of Trop2 exp. Results similar to ASCENT. Approved in China, may soon also reach the west (4th topo1 ADC). nature.com/articles/s4159…